Angiotensin II receptor type 1
Angiotensin II receptor type 1 (AT1 receptor) is a type of protein that is part of the renin-angiotensin system (RAS), which regulates blood pressure and fluid balance in the body. The AT1 receptor is primarily responsible for the vasoconstrictive effects of angiotensin II, a hormone that increases blood pressure.
Structure[edit]
The AT1 receptor is a G protein-coupled receptor (GPCR) that is composed of seven transmembrane domains. It is encoded by the AGTR1 gene in humans. The receptor is found in various tissues throughout the body, including the heart, kidney, and vascular smooth muscle.
Function[edit]
The primary function of the AT1 receptor is to mediate the effects of angiotensin II. When angiotensin II binds to the AT1 receptor, it triggers a series of intracellular events that result in vasoconstriction, increased aldosterone secretion, and increased vasopressin secretion. These actions collectively increase blood pressure and fluid balance.
Clinical significance[edit]
The AT1 receptor is a target for several types of antihypertensive drugs, including angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACE inhibitors). These drugs work by blocking the binding of angiotensin II to the AT1 receptor, thereby reducing its vasoconstrictive effects and lowering blood pressure.
See also[edit]
- Angiotensin II receptor type 2
- Renin-angiotensin system
- Angiotensin receptor blocker
- Angiotensin-converting enzyme inhibitor
References[edit]
This GPCR-related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian